Recurrent pericarditis occurred in one fifth of patients with systemic lupus erythematosus (SLE), with higher recurrence rates observed in younger patients and those receiving oral prednisone therapy.

Credit: Getty Images A discussion on the new American Heart Association’s pericarditis initiative with Jimmy Kerrigan, MD. For the estimated 40,000 adults with recurrent pericarditis in the United ...

Background Pericardium is considered electrically inert, but diffuse ST-elevation is an electrocardiographic marker of acute ...

Kiniksa Pharmaceuticals is set to begin a Phase 2/3 clinical trial for its drug KPL-387, aimed at treating recurrent pericarditis, in mid-2025. The company has noted that data from the ongoing Phase 1 ...

Designed to assess the impact of CardiolRx™ on preventing episodes of recurrent pericarditis, the first patient has been randomized by Northwestern University in Chicago. Based on a successful ...

DALLAS, June 17, 2024 — About 40,000 people in the United States experience recurrent pericarditis, or inflammation of the sac-like structure that protects the heart, which can cause chest pain and ...

Kiniksa Pharmaceuticals has partnered with country music star Carly Pearce and NHL Hall-of-Famer Henrik Lundqvist to raise awareness about recurrent pericarditis, a chronic heart condition that is ...

Rilonacept treatment resulted in a 96% reduction in risk of recurrent pericarditis events (primary efficacy endpoint: Hazard Ratio = 0.04, p<0.0001) Safety results consistent with FDA-approved label ...

This is a Designated News Release. Toronto, Ontario--(Newsfile Corp. - February 21, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life ...

Add Yahoo as a preferred source to see more of our stories on Google. The longtime New York Rangers star tells PEOPLE about managing his recurrent pericarditis diagnosis, the autoinflammatory disease ...